Press Room

Event

AAPS 2025 PharmSci 360

Start
Sunday, November 09, 2025
End
Wednesday, November 12, 2025
Location: San Antonio, TX, United States
Booth Number: 2943

Hovione is exhibiting at the AAPS 2025 PHarmSCi 360, a convener of the pharmaceutical science community, bringing together thousands of scientists from across the world. PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a small niche meeting because of its unique programming structure built on five tracks that cover the pharmaceutical development process. 

Don't miss our experts' presentations in San Antonio

Symposium Presentation, 302 ABC

Addressing Practical Challenges in CM via Novel Hardware and Automation

Monday, November 10 | 9:00 AM - 9:30 AM 

Speaker: Sarang Oka, Fellow Scientist - Technology Intensification

Short description: 

This work tackles critical operational challenges in continuous manufacturing processes for oral drug products, focusing on scalability, automation, and efficiency. Key issues include the complexity and manual nature of residence time distribution (RTD) experiments, non-automated execution of multi-point design of experiments (DOEs), and throughput limitations tied to existing continuous manufacturing equipment for oral solids. Innovative hardware and automation-based solutions have been developed to address the aforementioned challenges.

Key learnings of the session:

  • Participants will learn of automated, novel approaches to execute residence time distribution experiments in CM process trains.
  • Participants will learn of automated, novel approaches to execute DOEs in CM process trains, coupled with automated sampling with the goal of one-person DOE execution.
  • Participants will learn of a novel approach that combines batch and continuous processing in a single process train and how built-in modularity enables the operation over a wide throughput range.

Rapid Fire Presentation, 225 AB

Enhancing Biorelevance: Unveiling Enzymatic Impact on Simulated GI Dissolution

Monday, November 10 | 3:30 PM - 3:45 PM

Speaker: Catarina Chendo, MS, Analytical Scientist

Join Hovione at our poster presentations

Polymer Interactions with Dissolution Media: A Key Consideration in Method Development for Amorphous Solid Dispersions

Tuesday, November 11, 2025 | 9:30 AM - 10:30 AM

Presenting Author: Catarina Chendo, Analytical Scientist

Optimizing Biologics Formulation: Synthetic Sugars for Improved Stability and Viscosity

Tuesday, November 11, 2025 | 2:30 PM - 3:30 PM CT

Presenter (non-author): Inês Matos, R&D Manager

ASD Formulation to Unit Dosage Form: Integrated Drug Product Development with Dispersome

Tuesday, November 11, 2025 | 3:30 PM - 4:30 PM

Presenting Author: Inês Ramos, Ph.D., R&D Manager

Special poster collection

Optimizing Biologics Formulation: Synthetic Sugars for Improved Stability and Viscosity

Wednesday, November 12, 2025 | 10:30 AM - 11:25 AM 

Location: Poster Forum 4, Exhibit Hall 3&4

Speaker: Ines Matos, Hovione

 

Meet the Hovione team at booth # 2943

This is the perfect opportunity to speak with our experts and learn how a Specialist Integrated CDMO can deliver your entire project from one site, giving you the benefit of compressed timelines, seamless project management and knowledge, and increased sustainability.

Schedule a meeting today.

schedule a meeting
https://go.hovione.com/l/47122/2014-08-06/9grc

 

Also in the Press Room

See All

Every year, the largest bank in Portugal, Caixa Geral de Depósitos recognizes some of Portugal’s brightest young minds through the Caixa +Mundo Awards, providing nearly €800,000 in scholarships to students as they pursue higher education. In this year´s edition, Caixa named the award bestowed upon students pursuing science for Diane Villax. This prestigious honor places Diane Villax among the award’s namesakes – a distinguished group of prominent personalities who have made notable contributions to Portugal´s socio-economic, cultural, political and scientific development over the last 50 years, such as António Ramalho Eanes, Mário Soares, José Saramago, Sophia de Mello Breyner, Leonor Beleza, Elvira Fortunato, Rui Nabeiro, Américo Amorim, and José Manuel de Mello. Diane Villax will also honor the seven scientific award winners by personally meeting with each of them, and following their journeys as future innovators and leaders. But this honor is about far more than one individual. It is a celebration of an entire organization and the people behind it. For 67 years, generations of dedicated teams have worked together with passion, purpose, and excellence to manufacture life-saving medicines and advance science that has a real impact on people. This recognition belongs to all of us.    

News

Prestigious Caixa +Mundo Award named in honor of Diane Villax

May 14, 2026

CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing services. The companies partnered in 2023 with plans for development of two capsule-based devices for intranasal delivery: the single-use device and a multidose device. Read the full article at OINDPnews.com      

Press Clipping
OINDP - Orally inhaled and nasal drug products news, May 11, 2026

Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

May 11, 2026

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping
Contract Pharma, 7 May 2026

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026

Also in Events

See All